14 May 2013 14:12 [Source: ICIS news]
LONDON (ICIS)--Germany’s Evonik has formed a joint venture with US-based OPX Biotechnologies (OPXBIO) to developed bio-based specialty chemicals, it said on Tuesday.
The joint venture will use OPXBIO’s proprietary EDGE technology. EDGE, or "Efficiency Directed Genome Engineering", is a technology to develop bio-processes.
Financial, product or capacity details were not disclosed.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections